![](/img/cover-not-exists.png)
KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trials
Petrelli, Fausto, Coinu, Andrea, Cabiddu, Mary, Ghilardi, Mara, Barni, SandroVolume:
30
Language:
english
Journal:
Medical Oncology
DOI:
10.1007/s12032-013-0650-4
Date:
September, 2013
File:
PDF, 747 KB
english, 2013